PCN43 Risk of Recurrence Among Patients with HR-Positive, HER2-Negative, EARLY Breast Cancer Receiving Adjuvant Endocrine Therapy: A Systematic Review and Meta-Analysis

Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.180
https://www.valueinhealthjournal.com/article/S1098-3015(20)32436-0/fulltext
Title : PCN43 Risk of Recurrence Among Patients with HR-Positive, HER2-Negative, EARLY Breast Cancer Receiving Adjuvant Endocrine Therapy: A Systematic Review and Meta-Analysis
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32436-0&doi=10.1016/j.jval.2020.08.180
First page :
Section Title :
Open access? : No
Section Order : 10138
Categories :
Tags :
Regions :
ViH Article Tags :